Combination therapy shows promising results in treating stage 3 melanoma
Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3 cutaneous
Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3 cutaneous
Mount Sinai researchers have enhanced hospital screening protocols for Candida auris, an often-drug-resistant fungal pathogen the Centers for Disease Control and Prevention considers an urgent
Today, Prof. Howard Feldman presented revised diagnostic criteria for Alzheimer’s disease at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid on behalf of
As part of ongoing work to define and advance high-quality cancer care globally, leaders from the National Comprehensive Cancer Network (NCCN)-;an alliance of leading cancer
Groundbreaking research exploring the experiences of autistic psychiatrists has revealed that psychiatrists who are unaware that they themselves are autistic may fail to recognise the
Newly published research in the journal Glia has identified crucial links between dietary choices and the progression of multiple sclerosis (MS).
The first 3D images of a whole human thymus have been created using a specialized X-ray technique by researchers from UCL and the Francis Crick
Stents to treat various blockages in the human body can themselves become blocked, but a new sensor developed at the University of Michigan for stents
University of Queensland-led research has found inflammatory markers in the blood of long COVID patients which could explain why many experience ongoing cardiovascular issues.
WASHINGTON — The hospital industry has pushed back against Medicare payment reforms for years, arguing that the policies would financially hurt rural hospitals. Two key